CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
130 hedge funds and large institutions have $251M invested in Cymabay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 32
62% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $3.45M
Holders
130
Holding in Top 10
3
Calls
$1.32M
Puts
$3.45M
Top Buyers
| 1 | +$6.8M | |
| 2 | +$3.21M | |
| 3 | +$2.6M | |
| 4 |
Renaissance Technologies
New York
|
+$2.18M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.13M |
Top Sellers
| 1 | -$4.28M | |
| 2 | -$3.85M | |
| 3 | -$3.36M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.28M |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$2.36M |